90 related articles for article (PubMed ID: 23708448)
21. Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemias.
Karp JE; Passaniti A; Gojo I; Kaufmann S; Bible K; Garimella TS; Greer J; Briel J; Smith BD; Gore SD; Tidwell ML; Ross DD; Wright JJ; Colevas AD; Bauer KS
Clin Cancer Res; 2005 Dec; 11(23):8403-12. PubMed ID: 16322302
[TBL] [Abstract][Full Text] [Related]
22. Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells.
Spinella MJ; Kitareewan S; Mellado B; Sekula D; Khoo KS; Dmitrovsky E
Oncogene; 1998 Jul; 16(26):3471-80. PubMed ID: 9692555
[TBL] [Abstract][Full Text] [Related]
23. Novel alterations in CDK1/cyclin B1 kinase complex formation occur during the acquisition of a polyploid DNA content.
Datta NS; Williams JL; Caldwell J; Curry AM; Ashcraft EK; Long MW
Mol Biol Cell; 1996 Feb; 7(2):209-23. PubMed ID: 8688553
[TBL] [Abstract][Full Text] [Related]
24. Icariside II induces cell cycle arrest and differentiation via TLR8/MyD88/p38 pathway in acute myeloid leukemia cells.
Yang J; Lan J; Du H; Zhang X; Li A; Zhang X; Liu Y; Zhang J; Zhang C; Ding Y; Zhang T
Eur J Pharmacol; 2019 Mar; 846():12-22. PubMed ID: 30579933
[TBL] [Abstract][Full Text] [Related]
25. A Novel Glycogen Synthase Kinase-3 Inhibitor Optimized for Acute Myeloid Leukemia Differentiation Activity.
Hu S; Ueda M; Stetson L; Ignatz-Hoover J; Moreton S; Chakrabarti A; Xia Z; Karan G; de Lima M; Agrawal MK; Wald DN
Mol Cancer Ther; 2016 Jul; 15(7):1485-1494. PubMed ID: 27196775
[TBL] [Abstract][Full Text] [Related]
26. Cyclin B1 and CDK1: nuclear localization and upstream regulators.
Porter LA; Donoghue DJ
Prog Cell Cycle Res; 2003; 5():335-47. PubMed ID: 14593728
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of all-trans-retinoic acid-induced proteasome activation potentiates the differentiating effect of retinoid in acute myeloid leukemia cells.
Fang Y; Zhou X; Lin M; Ying M; Luo P; Zhu D; Lou J; Yang B; He Q
Mol Carcinog; 2011 Jan; 50(1):24-35. PubMed ID: 20945414
[TBL] [Abstract][Full Text] [Related]
28. Increased cdc2 and cdk2 kinase activity by retinoid X receptor gamma-mediated transcriptional down-regulation of the cyclin-dependent kinase inhibitor p21Cip1/WAF1 correlates with terminal differentiation of squamous cell carcinoma lines.
Crowe DL; Shuler CF
Cell Growth Differ; 1998 Aug; 9(8):619-27. PubMed ID: 9716179
[TBL] [Abstract][Full Text] [Related]
29. Oncogenic retinoic acid receptor γ knockdown reverses multi-drug resistance of human colorectal cancer via Wnt/β-catenin pathway.
Huang GL; Song W; Zhou P; Fu QR; Lin CL; Chen QX; Shen DY
Cell Cycle; 2017 Apr; 16(7):685-692. PubMed ID: 28272990
[TBL] [Abstract][Full Text] [Related]
30. Two Distinct Cdc2 Pools Regulate Cell Cycle Progression and the DNA Damage Response in the Fission Yeast S.pombe.
Caspari T; Hilditch V
PLoS One; 2015; 10(7):e0130748. PubMed ID: 26131711
[TBL] [Abstract][Full Text] [Related]
31. Retinoic acid regulates cell cycle progression and cell differentiation in human monocytic THP-1 cells.
Chen Q; Ross AC
Exp Cell Res; 2004 Jul; 297(1):68-81. PubMed ID: 15194426
[TBL] [Abstract][Full Text] [Related]
32. Cdk1 coordinates cell-surface growth with the cell cycle.
McCusker D; Denison C; Anderson S; Egelhofer TA; Yates JR; Gygi SP; Kellogg DR
Nat Cell Biol; 2007 May; 9(5):506-15. PubMed ID: 17417630
[TBL] [Abstract][Full Text] [Related]
33. p38αMAPK interacts with and inhibits RARα: suppression of the kinase enhances the therapeutic activity of retinoids in acute myeloid leukemia cells.
Gianni M; Peviani M; Bruck N; Rambaldi A; Borleri G; Terao M; Kurosaki M; Paroni G; Rochette-Egly C; Garattini E
Leukemia; 2012 Aug; 26(8):1850-61. PubMed ID: 22354283
[TBL] [Abstract][Full Text] [Related]
34. Cdk1 and Cdk2 complexes (cyclin dependent kinases) in apoptosis: a role beyond the cell cycle.
Golsteyn RM
Cancer Lett; 2005 Jan; 217(2):129-38. PubMed ID: 15617830
[TBL] [Abstract][Full Text] [Related]
35. RARγ-C-Fos-PPARγ2 signaling rather than ROS generation is critical for all-trans retinoic acid-inhibited adipocyte differentiation.
Wang X; Yang P; Liu J; Wu H; Yu W; Zhang T; Fu H; Liu Y; Hai C
Biochimie; 2014 Nov; 106():121-30. PubMed ID: 25173565
[TBL] [Abstract][Full Text] [Related]
36. Allosteric Regulation of Cyclin-B Binding by the Charge State of Catalytic Lysine in CDK1 Is Essential for Cell-Cycle Progression.
Deota S; Rathnachalam S; Namrata K; Boob M; Fulzele A; Radhika S; Ganguli S; Balaji C; Kaypee S; Vishwakarma KK; Kundu TK; Bhandari R; Gonzalez de Peredo A; Mishra M; Venkatramani R; Kolthur-Seetharam U
J Mol Biol; 2019 May; 431(11):2127-2142. PubMed ID: 30974121
[TBL] [Abstract][Full Text] [Related]
37. Induction of apoptosis in human leukemia cells by the CDK1 inhibitor CGP74514A.
Dai Y; Dent P; Grant S
Cell Cycle; 2002; 1(2):143-52. PubMed ID: 12429924
[TBL] [Abstract][Full Text] [Related]
38. Inactivation of Cdk1/Cyclin B in metaphase-arrested mouse FT210 cells induces exit from mitosis without chromosome segregation or cytokinesis and allows passage through another cell cycle.
Paulson JR
Chromosoma; 2007 Apr; 116(2):215-25. PubMed ID: 17256109
[TBL] [Abstract][Full Text] [Related]
39. All-Trans Retinoic Acid Activity in Acute Myeloid Leukemia: Role of Cytochrome P450 Enzyme Expression by the Microenvironment.
Su M; Alonso S; Jones JW; Yu J; Kane MA; Jones RJ; Ghiaur G
PLoS One; 2015; 10(6):e0127790. PubMed ID: 26047326
[TBL] [Abstract][Full Text] [Related]
40. Cyclin B1/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance.
Xie B; Wang S; Jiang N; Li JJ
Cancer Lett; 2019 Feb; 443():56-66. PubMed ID: 30481564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
